Atlas Trials

Nimotuzumab Plus Nab-paclitaxel and Cisplatin in Treating Patients With Advanced Esophageal Carcinoma

Clinical trial NCT02034968 · WITHDRAWN

Trial details

NCT number
NCT02034968
Sponsor
Zhejiang University
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Stage IV Esophageal Squamous Cell Carcinoma
Start date
2014-02-01
Primary completion
2016-01-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.